CELTEGRIS Trademark

Trademark Overview

On Tuesday, July 10, 2001, a trademark application was filed for CELTEGRIS with the United States Patent and Trademark Office. The USPTO has given the CELTEGRIS trademark a serial number of 76282895. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Wednesday, June 18, 2003. This trademark is owned by Human Genome Sciences, Inc.. The CELTEGRIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in promoting the growth and repair of epithelial cells; pharmaceutical preparations for use in the treatment of alimentary tract disorders, allergic conditions, autoimmune diseases, blood disorders, bone diseases and injuries, bone marrow and stem cell transplantation, cardiovascular diseases, central nervous system disorders, connective tissue disorders, critical care, ear, nose and throat conditions, endocrinology disorders, gastrointestinal diseases, genetic disease, immunologic conditions, infectious diseases, joint diseases, kidney diseases, liver diseases, metabolic diseases, neurologic disorders, nutritional disorders, obstetric, gynecological and reproductive disorders, oncologic conditions, ophthalmologic diseases, organ transplantation, pancreatic disorders, poisoning, psychiatric disorders, respiratory diseases, dermatologic disorders, substance abuse disorders, thrombotic diseases, vascular diseases, tendon and muscular injuries, back inj...
celtegris

General Information

Serial Number76282895
Word MarkCELTEGRIS
Filing DateTuesday, July 10, 2001
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateWednesday, June 18, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 24, 2002

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in promoting the growth and repair of epithelial cells; pharmaceutical preparations for use in the treatment of alimentary tract disorders, allergic conditions, autoimmune diseases, blood disorders, bone diseases and injuries, bone marrow and stem cell transplantation, cardiovascular diseases, central nervous system disorders, connective tissue disorders, critical care, ear, nose and throat conditions, endocrinology disorders, gastrointestinal diseases, genetic disease, immunologic conditions, infectious diseases, joint diseases, kidney diseases, liver diseases, metabolic diseases, neurologic disorders, nutritional disorders, obstetric, gynecological and reproductive disorders, oncologic conditions, ophthalmologic diseases, organ transplantation, pancreatic disorders, poisoning, psychiatric disorders, respiratory diseases, dermatologic disorders, substance abuse disorders, thrombotic diseases, vascular diseases, tendon and muscular injuries, back injuries and joint injuries, skin wound and soft tissue wounds

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 20, 2001
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHuman Genome Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameHuman Genome Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Thursday, September 11, 2003ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 17, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 24, 2002PUBLISHED FOR OPPOSITION
Wednesday, September 4, 2002NOTICE OF PUBLICATION
Wednesday, June 26, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 24, 2002EXAMINERS AMENDMENT MAILED
Thursday, June 20, 2002PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, June 18, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 20, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 29, 2001NON-FINAL ACTION MAILED
Saturday, August 25, 2001ASSIGNED TO EXAMINER

Related Keywords

celtegris diseases disorders conditions transplantation pharmaceutical bone injuries preparations nutritional obstetric